482 related articles for article (PubMed ID: 21633595)
1. Silybin and the liver: from basic research to clinical practice.
Loguercio C; Festi D
World J Gastroenterol; 2011 May; 17(18):2288-301. PubMed ID: 21633595
[TBL] [Abstract][Full Text] [Related]
2. Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years.
Federico A; Dallio M; Loguercio C
Molecules; 2017 Jan; 22(2):. PubMed ID: 28125040
[TBL] [Abstract][Full Text] [Related]
3. Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases.
Abenavoli L; Izzo AA; Milić N; Cicala C; Santini A; Capasso R
Phytother Res; 2018 Nov; 32(11):2202-2213. PubMed ID: 30080294
[TBL] [Abstract][Full Text] [Related]
4. Recapitulation of Evidence of Phytochemical, Pharmacokinetic and Biomedical Application of Silybin.
Islam A; Mishra A; Siddiqui MA; Siddiquie S
Drug Res (Stuttg); 2021 Nov; 71(9):489-503. PubMed ID: 34318464
[TBL] [Abstract][Full Text] [Related]
5. Superior silybin bioavailability of silybin-phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers.
Méndez-Sánchez N; Dibildox-Martinez M; Sosa-Noguera J; Sánchez-Medal R; Flores-Murrieta FJ
BMC Pharmacol Toxicol; 2019 Jan; 20(1):5. PubMed ID: 30635055
[TBL] [Abstract][Full Text] [Related]
6. Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations.
Brantley SJ; Oberlies NH; Kroll DJ; Paine MF
J Pharmacol Exp Ther; 2010 Mar; 332(3):1081-7. PubMed ID: 19934397
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of silymarin, a milk thistle (Silybium marianum) derivative on ethanol-induced oxidative stress in liver.
Das SK; Vasudevan DM
Indian J Biochem Biophys; 2006 Oct; 43(5):306-11. PubMed ID: 17133738
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant activity of silybin in vivo during long-term iron overload in rats.
Pietrangelo A; Borella F; Casalgrandi G; Montosi G; Ceccarelli D; Gallesi D; Giovannini F; Gasparetto A; Masini A
Gastroenterology; 1995 Dec; 109(6):1941-9. PubMed ID: 7498660
[TBL] [Abstract][Full Text] [Related]
9. Metabolism, Transport and Drug-Drug Interactions of Silymarin.
Xie Y; Zhang D; Zhang J; Yuan J
Molecules; 2019 Oct; 24(20):. PubMed ID: 31615114
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability of a silybin-phosphatidylcholine complex in dogs.
Filburn CR; Kettenacker R; Griffin DW
J Vet Pharmacol Ther; 2007 Apr; 30(2):132-8. PubMed ID: 17348898
[TBL] [Abstract][Full Text] [Related]
11. Identification of hepatoprotective flavonolignans from silymarin.
Polyak SJ; Morishima C; Lohmann V; Pal S; Lee DY; Liu Y; Graf TN; Oberlies NH
Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5995-9. PubMed ID: 20231449
[TBL] [Abstract][Full Text] [Related]
12. Hepatoprotective and antifibrotic effect of a new silybin-phosphatidylcholine-Vitamin E complex in rats.
Di Sario A; Bendia E; Taffetani S; Omenetti A; Candelaresi C; Marzioni M; De Minicis S; Benedetti A
Dig Liver Dis; 2005 Nov; 37(11):869-76. PubMed ID: 16169303
[TBL] [Abstract][Full Text] [Related]
13. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos).
Kidd P; Head K
Altern Med Rev; 2005 Sep; 10(3):193-203. PubMed ID: 16164374
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant properties of silybin glycosides.
Kosina P; Kren V; Gebhardt R; Grambal F; Ulrichová J; Walterová D
Phytother Res; 2002 Mar; 16 Suppl 1():S33-9. PubMed ID: 11933137
[TBL] [Abstract][Full Text] [Related]
15. Silybin and silymarin--new and emerging applications in medicine.
Gazák R; Walterová D; Kren V
Curr Med Chem; 2007; 14(3):315-38. PubMed ID: 17305535
[TBL] [Abstract][Full Text] [Related]
16. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.
Pradhan SC; Girish C
Indian J Med Res; 2006 Nov; 124(5):491-504. PubMed ID: 17213517
[TBL] [Abstract][Full Text] [Related]
17. Silymarin is an ally against insulin resistance: A review.
MacDonald-Ramos K; Michán L; Martínez-Ibarra A; Cerbón M
Ann Hepatol; 2021; 23():100255. PubMed ID: 32950646
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts.
Kidd PM
Altern Med Rev; 2009 Sep; 14(3):226-46. PubMed ID: 19803548
[TBL] [Abstract][Full Text] [Related]
19. Silymarin liposomes improves oral bioavailability of silybin besides targeting hepatocytes, and immune cells.
Kumar N; Rai A; Reddy ND; Raj PV; Jain P; Deshpande P; Mathew G; Kutty NG; Udupa N; Rao CM
Pharmacol Rep; 2014 Oct; 66(5):788-98. PubMed ID: 25149982
[TBL] [Abstract][Full Text] [Related]
20. Oxidised derivatives of silybin and their antiradical and antioxidant activity.
Gazák R; Svobodová A; Psotová J; Sedmera P; Prikrylová V; Walterová D; Kren V
Bioorg Med Chem; 2004 Nov; 12(21):5677-87. PubMed ID: 15465345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]